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Exploring Polymorphism and Stoichiometric Diversity in 
Naproxen/Proline Cocrystals  
Natalia Tumanovaa, Nikolay Tumanovb, Franziska Fischerc, Fabrice Morellea, Voraksmy Band, Koen 
Robeynsa, Yaroslav Filinchuka, Johan Woutersb, Franziska Emmerlingc and Tom Leyssens*a  
We present naproxen/proline cocrystals discovered when combining enantiopure and racemic naproxen and proline. 
Using liquid-assisted grinding as a main method to explore the variaty of crystal forms in this system, we found 17 
cocrystals, the structures of only four of them were previously known. Naproxen/proline system exhibited multiple 
polymorphs of 1:1 stoichiometry, as well as more rare cocrystals with 1:2 and 2:3 stoichiometries, two cocrystal hydrates 
and one cocrystal solvate.  In situ ball-milling, used to monitor liquid-assisted grinding reactions, revealed that solvent 
dictates the reaction intermediates, even if the final reaction product stays the same. Synchrotron X-ray diffraction data 
collected in situ upon heating allowed us to monitor directly phase changes upon heating and gave access to pure 
diffraction patterns of several cocrystals thus enabling their structure determination from powder X-ray diffraction data; 
this method also confirmed the formation of a conglomerate in the RS-naproxen/DL-proline system. Proline in cocrystals 
kept its ability to form charge-assisted head-to-tail N–H…O hydrogen bonds, typical of pure crystalline amino acids, thus 
increasing the percentage of strong charge-assisted interactions in the structure and consequently providing some of the 
cocrystals with higher melting points as compared to pure naproxen. The majority of drugs are chiral, and hence, these 
data are of importance to pharmacetical industry as they provide insight into challenges of chiral cocrystallization.  
Introduction 
Multicomponent crystalline systems had been known long 
before the term “cocrystal” gained its popularity.1,2 The field of 
cocrystallization and the concept of crystal engineering has 
especially flourished in the last decades. Engineering cocrystals 
has become a widespread solution to various structure-
property related problems, e.g., improving therapeutic 
performance of drugs in pharmaceutical industry3–5 or tuning 
properties of thermo- and photochromic materials, molecular 
semiconductors and optical materials.6–10 
Chiral cocrystals are of special importance in pharmaceutical 
industry as a substantial part of drugs are chiral.11 Knowing 
how the enantiomeric or racemic forms of the same drug 
would respond to cocrystallization with chiral and/or non-
chiral coformers, i.e., the differences in both the structure and 
properties of those cocrystals, their ability to cocrystallization, 
production related issues, is essential in developing robust and 
effective crystallization processes. There have been a number 
of works in this area. For instance, caffeine and theophylline 
were found to respond differently to cocrystallization with DL- 
and D-tartaric acid.12,13 Enantiospecific behavior, when only 
one of the enantiomers was found to form a cocrystal with a 
certain chiral coformer, was reported for various systems, e.g., 
the stanolone/tartaric acid14, cyclohexandiol/tartaric acid15, 
levetiracetam/mandelic acid and levetiracetam/tartaric acid16, 
naproxen/tyrosine17 systems.  This property of chiral cocrystals 
was used to develop alternative chiral resolution techniques 
based on cocrystallization.18–24 
Amino acids, except glycine, are chiral. Their use in 
pharmaceutical industry as potential coformers can be 
advantageous as they are natural to the body and thus present 
significantly lower risks in comparison with other coformers. 
Amino acids are zwitterionic in the crystalline state and tend to 
form head-to-tail charge-assisted hydrogen bonded chains25–27 
that are also observed in cocrystals17,28; this structural feature 
of amino acids may help to improve the API’s properties, for 
instance by increasing stability, as the percentage of strong 
interactions in the structure grows.29 
Proline is special as, unlike other amino acids, its amino group 
is found within the pyrrolidine ring. It showed a good ability to 
cocrystallize with various compounds for multiple applications, 
i.e., to alter physicochemical properties of drugs30–35, for chiral 
resolution36–38, to develop an amino acid derived 
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semiconductor39, etc. Proline has also been used for ionic 
cocrystal formation to investigate the possibilities of chiral 
resolution in the solid state40. 
In our recent work, we combined enantiopure and racemic 
forms of flurbiprofen and proline and, with the help of various 
state-of-the-art characterization methods, identified 17 
cocrystals.41 In this work, we chose another model compound, 
naproxen, to study cocrystallization of chiral coformers. 
Naproxen is a nonsteroidal anti-inflammatory drug poorly 
soluble in water; several cocrystals of naproxen have already 
been developed with the purpose of modifying its properties.42 
Its cocrystallization with amino acids may suggest an 
alternative way to improve its therapeutic performance. 
Naproxen has already shown its ability to cocrystallize with 
amino acids, such as alanine, tryptophan, tyrosine17, 
arginine43. In addition, several cocrystals of naproxen (nprx) 
and proline (pro) have been previously reported.28 In this 
work, applying a combination of modern characterization 
methods, including synchrotron X-ray diffraction upon various 
conditions, we discovered multiple previously unknown 
nprx/pro cocrystal phases. The nprx/pro system, with its 17 
cocrystals (including two cocrystal hydrates and one cocrystal 
solvate) and one conglomerate, is another fascinating example 
of complexity that can be reached in a chiral system when 
using pro as a coformer. 
Experimental 
Experimental procedures are described below, except the 
procedure for the production of single crystals and structure 
determination from single-crystal and powder X-ray diffraction 
data which are given in ESI. 
Materials 
All the compounds for this work were purchased from Sigma-
Aldrich and used without further purification. The reference 
diffraction patterns of the initial compounds were simulated 
using the Mercury software44 from the corresponding 
structures found in the Cambridge Structural Database: S-nprx 
(CCDC COYRUD45,  COYRUD1146, and COYRUD1247), RS-nprx 
(CCDC PAPTUX48 and PAPTUX0149), L-pro (CCDC PROLIN50, 
PROLIN0241, and PROLIN0341), L-pro monohydrate (CCDC 
RUWGEV51), DL-pro (CCDC QANRUT52 and QANRUT0153), and 
DL-pro monohydrate (CCDC  DLPROM0154). 
Laboratory liquid-assisted grinding (LAG) and laboratory powder 
X-ray diffraction analysis. 
Liquid-assisted grinding in the presence of five different 
solvents, methanol (MeOH), ethanol (EtOH), isopropanol 
(ISPN), acetonitrile (ACN), and water was performed for five 
combinations of enantiopure and racemic nprx and pro: S-
nprx/L-pro, S-nprx/D-pro, S-nprx/DL-pro, RS-nprx/L-pro, and 
RS-nprx/DL-pro. The compounds were ground in 1:1, 1:2, 2:3, 
and 2:1 ratios. To prepare each sample, 50-100 mg of total 
powder were placed into 2 mL Eppendorf tube, 2-10 μL of 
solvent were added, along with 5-6 stainless steel 2 mm balls 
to ensure grinding; the Eppendorf tubes were placed into a 
Retsch MM400 mixer mill for 60 min at a frequency of 30 Hz. 
Resultant powders were analyzed by powder X-ray diffraction 
(PXRD), CuKα radiation, using a Siemens D5000 diffractometer 
(2θ was scanned from 2 to 50° with a step of 0.02°) or a X’pert 
PRO PANalytical diffractometer (2θ scanned from 4 to 50° with 
a step of 0.017°). Collected diffraction patterns were analyzed 
by comparison with those of initial pure compounds and other 
known cocrystal phases in order to identify whether or not 
anything new formed. 
Some samples were chosen for further analysis by other 
methods. All LAG experiments, their outcome, and 
characterization methods are summarized in Tables S4.1, S5.1, 
S6.1, S7.1, S8.1, and S9.1. 
In situ synchrotron variable temperature X-ray diffraction data 
collection. 
Selected powders obtained by liquid-assisted grinding were 
packed into 0.5 mm glass capillaries and measured upon 
heating at a rate of 2 °C/min. All powder diffraction data, 
except in situ experiment for the 1:1 RS-nprx/L-pro/H2O  
(sample 17 in Table S7.1) and 1:1 RS-nprx/DL-pro/H2O (sample 
17 in Table S8.1), were collected using synchrotron radiation 
source: MS-X04SA beam line at the Swiss Light Source (SLS) 
(PSI, Switzerland) equipped with a 1D microstrip detector 
MYTHEN II. The measurements were performed at 
λ = 0.77663, 0.62173, 0.708 Å with a step of 0.0036°. The 
wavelength was calibrated using a standard NIST 640d Si 
sample. Selected diffraction patterns were used for structure 
determination from X-ray powder data. The 1:1 RS-nprx/L-
pro/H2O (sample 17 in Table S7.1) and 1:1 RS-nprx/DL-
pro/H2O (sample 17 in Table S8.1) were measured at the 
Swiss-Norwegian beamline BM1A at the European Synchrotron 
Radiation Facility (ESRF) (Grenoble, France), using a 
PILATUS 2M hybrid pixel detector at a wavelength of 
0.78487  Å. 
 
In situ ball-milling synchrotron X-ray diffraction data collection. 
In situ ball-milling X-ray diffraction experiments were 
performed at the μSpot beamline (BESSY II, Helmholtz Centre 
Berlin for Materials and Energy, Germany) using a 
Pulverisette 23 (Fritsch, Germany) ball mill and Perspex jars; 
the frequency was 50 Hz. Compounds were mixed and the 
solvent and 3 stainless 5 mm steel balls were added right 
before the experiment. Details for each experiment (duration 
of milling, amount of solvent, amounts of initial compounds) 
are summarized in Table S3.1 A beam diameter of 100 μm at a 
photon flux of 1 × 109 s −1 at a ring current of 100 mA was 
used. The experiments were performed at a wavelength of 
1.000 Å using a double crystal monochromator Si (111). The 
spot size on the sample was 200 μm. Scattered intensities 
were collected with a two-dimensional X-ray detector 
(MarMosaic, CCD 3072 × 3072 pixels, pixel size 73 μm)55. 
Measurements were carried out every 30 s with a delay time 
of 3 or 4 s between two measurements. The occasionally 
observed doubling of reflections is caused by diffraction of two 
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different areas in the reaction jar, due to differences in the 
distance between the detector and the sample. Obtained two-
dimensional diffraction images were integrated (2θ vs 
intensity) using the program Fit2D56. Diffraction patterns were 
background corrected and plotted as 2D film representation 
using the Powder3D program57. 
Differential scanning calorimetry (DSC) and thermogravimetric 
analysis (TGA).  
DSC curves were measured using a DSC 821 Mettler Toledo 
instrument. Prior to measurements, the instrument was 
calibrated using indium. Standard 40 μL aluminum crucibles 
were used. The heating rate was 2 °C/min over the range from 
25 to 200-250 °C. All experiments were carried out under 
nitrogen atmosphere (a flow rate of 50 ml/min). DSC curves of 
the selected samples are given in ESI.  
DSC data were used to select multiphase samples and to 
determine melting points when possible. Samples with 
complicated DSC curve shapes were further analyzed in situ 
using variable-temperature synchrotron radiation in order to 
identify and directly monitor phase changes upon heating. It 
should be noted that direct matching of the DSC and in situ 
synchrotron PXRD data may not be always reliable due to 
different experimental setups; however, in situ synchrotron 
PXRD data provide a more profound view and might help in 
interpretation of the DSC data. 
TGA curve was measured in order to determine the number of 
water molecules in the asymmetric unit of the 1:1 S/DL/H2O 
cocrystal hydrate (sample 17 in Table S9.1) needed to solve the 
structure of this phase from PXRD. The measurement was 
performed in the temperature range from 25 to 400 °C and at 
a heating rate of 5 °C/min using a Mettler Toledo TGA/DSC 3+ 
instrument; the obtained TGA curve is given in Fig. S9.3.6. 
 
Results and Discussion 
We studied five combinations of enantiopure and racemic 
naproxen and proline: S-nprx/L-pro (=R-nprx/D-pro), S-
nprx/D-pro (=R-nprx/L-pro), S-nprx/DL-pro (=R-nprx/DL-pro), 
RS-nprx/L-pro (=RS-nprx/D-pro), and RS-nprx/DL-pro. The 
main approach to explore cocrystal phases was liquid-assisted 
grinding (LAG); solution cocrystallization was used only to 
produce single crystals. The advantages of LAG were outlined 
in our previous work41, where this method proved highly 
efficient. LAG was performed in the presence of the following 
five solvents and varying the ratio of the initial compounds: 
methanol (MeOH), ethanol (EtOH), isopropanol (ISPN), 
acetonitrile (ACN), and water. The solvents were chosen so 
that at least one of the initial compounds will be well soluble: 
nprx is relatively well soluble in all the solvents except water, 
whereas pro exhibits decent solubility only in MeOH, EtOH, 
and water. Powders obtained after LAG reactions were 
subjected first to simple laboratory PXRD analysis in order to 
identify known phases, then DSC analysis was performed for 
selected samples in order to check for both the purity of the 
samples and any occurring phase transformations, as well as to 
determine the melting points if possible. The samples that 
exhibited complicated DSC curves with multiple peaks were 
further subjected to variable-temperature in situ synchrotron 
X-ray diffraction analysis to gain a direct insight into phase 
changes. The structures of those cocrystal phases for which we 
failed to grow sufficiently big single-crystals for single-crystal 
X-ray diffraction analysis were solved from powder X-ray 
diffraction data collected using synchrotron radiation. Scheme 
1 gives an overview of the results. As all the combinations, 
except S/D, resulted in multiple cocrystal phases, we decided 
to perform in situ ball-milling experiments monitored by 
synchrotron radiation in order to get a deeper insight into 
mechanochemical reactions. Each combination is discussed 
below in detail. The structures of obtained cocrystals are 
discussed in the Structural Analysis section.  
Scheme 1. A schematic summary of all the found cocrystals for the five nprx/pro 
combinations. Already known cocrystal phases and the phases whose structures 
were determined from powder X-ray diffraction data are marked as ‘†’ and ‘*’, 
respectively; the structures of all the other left phases were determined from 
single-crystal X-ray diffraction data. 
S-naproxen/L-proline (S/L) 
S/L system yielded the richest variety of cocrystals, including 
cocrystals with a different stoichiometry. All the cocrystals 
whose structures were determined can be found in  Scheme 1.  
Preliminary laboratory LAG experiments with a series of 
solvents (MeOH, EtOH, ISPN, and ACN) did not allow us to 
draw any reliable conclusions about whether or not the 
reaction outcome is solvent-dependent: all the phases seemed 
to have chances to emerge. Table S4.1 summarizes the 
outcomes of the laboratory LAG experiments. From this table 
we see that, among the 1:1 forms, 1:1 S/L pol I (CCDC REF 
FEVZUD28) seemed to emerge more often in MeOH- and EtOH-
LAG reactions, whereas ACN- and ISPN-LAG resulted mainly in 
the 1:1 S/L pol II. However, some samples contained both 
polymorphs in varied amounts. LAG reactions when pro was 
taken in an excess amount (1:2 and 2:3 nprx : pro ratios) 
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showed the formation of the 2:3 S/L cocrystal, whereas the 2:1 
nprx : pro ratio yielded mainly 1:1 S/L polymorphs. The 1:2 S/L  
Figure. 1 In situ ball-milling X-ray diffraction patterns for the S/L system, λ = 1 Å, 
1:1 ratio: (a) MeOH-, (b) EtOH-, (c) ISPN-, and (d) ACN-LAG. Colored bands on the 
right side of each image represent the presence of phases and are shown only 
for illustrative purpos; the area outlined by purple in (c) and (d) shows the 
presence of the unknown phase I 
cocrystal that was crystallized from solution during our 
attempts to obtain single crystals was detected only in 1:2 
water-LAG and 2:3 ISPN-LAG (see samples 12 and 18 in Table 
S4.1) and not in any other LAG reactions, even if the initial 
ratio of the components was 1:2 (see samples 2, 6, 10, and 14 
in Table S4.1). As can be seen from Table S4.1, most of the 
laboratory LAG experiments led to product mixtures, which 
means that the cocrystal phases kinetically compete with one 
another. We performed in situ ball-milling experiments in 
order to gain insight into the grinding process and directly 
monitor the phase changes in the course of the reaction. The 
results are presented in Figure 1. 
All the in situ monitored LAG reactions finally led to the 
1:1 S/L pol II phase, but the pathway differed (samples 1-4 in 
Table S3.1). In MeOH- and EtOH-LAG, a mixture of the 1:1 S/L 
pol I and 2:3 S/L preceded the formation of the 1:1 S/L pol II 
(Figures 1a, b; Fig. S3.1.1 and S3.1.2) and disappeared by the 
6th minute of reaction,  thus indicating that the former phases 
are more kinetically favored under these conditions, but not 
stable enough to withstand further grinding. In ISPN- and ACN-
LAG (Figures 1c, d), we saw an unknown phase emerging in the 
beginning and then disappearing during the course of reaction 
(we called it unknown phase I), which thus was as well less 
stable, but kinetically faster than 1:1 S/L pol II under those 
grinding conditions. Hence, in situ ball-milling experiments 
showed that varying the solvent affects the reaction pathway, 
by revealing the formation of different phases that precede 
the main 1:1 S/L pol II phase depending on the solvent used – 
the result that was not apparent in the laboratory 
experiments. 
In situ ball-milling reaction outcomes differed from those 
obtained by 1:1 laboratory LAG: in laboratory experiments 
(1:1 ratio) both 1:1 S/L pol I and 1:1 S/L pol II had chances to 
emerge, unlike the in situ ball-milled powders that contained 
only pol II as the final reaction product, no matter which 
solvent was used. This result can be explained by the fact that 
grinding reactions may be very sensitive to the ball-milling 
setup (the amount of powder, the diameter of balls, the 
volume of liquid added per total amount of powder, the jar’s 
configuration and the material the jar is made of, etc.).  
However, despite the difference, we can still make some 
parallels between the laboratory and in situ ball-milling data. 
For instance, the precedence of the 1:1 S/L pol I to the 
emergence of the 1:1 S/L pol II in MeOH-LAG (Figure 1a) 
indicates that these two polymorphs compete with each other, 
which explains why in some 1:1 laboratory grinding reactions 
we obtained one or another or both polymorphs at the same 
time, depending on the conditions. 
DSC curves measured for selected samples (see Figs. S4.3.1-
S4.3.5) had complex shapes with multiple peaks. This is why 
we decided to measure variable-temperature in situ 
synchrotron PXRD for those samples in order to monitor phase 
changes upon heating. 
Figure 2. PXRD patterns measured in situ upon heating (from 37 to 159 °C, 
2 °C/min) for the S/L sample prepared by 1:1 ACN-LAG (sample 13 in Table S4.1), 
λ = 0.708 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 37 °C – 1:1 S/L pol I and 1:1 S/L pol II; T = 109 °C –
 1:1 S/L pol II; and T = 139 °C – 2:3 S/L 
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The first example of a variable-temperature in situ experiment 
is presented in Figure 2. The initial sample obtained by 1:1 
ACN-LAG contained a mixture of two 1:1 polymorphs: pol I and 
pol II. Upon heating the 1:1 S/L pol I disappeared, leaving only 
pol II in the sample. Upon further heating, the disappearance 
of the 1:1 S/L pol II was followed by the emergence of the 
2:3 S/L.  
Figure 3. PXRD patterns measured in situ upon heating (from 46 to 179 °C, 
2 °C/min) for the S/L sample prepared by 1:1 EtOH-LAG (sample 5 in Table S4.1), 
λ = 0.62127 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 46 °C – 1:1 S/L pol I; T = 137 °C – 2:3 S/L and unknown phase 
II; and T = 147 °C – 2:3 S/L. 
The second example of a variable temperature in situ 
experiment is presented in Figure 3. The sample obtained by 
1:1 EtOH-LAG reaction initially contained only 1:1 S/L pol I. 
Upon heating, the 1:1 S/L pol I phase disappeared followed by 
the emergence of the 2:3 S/L and unknown phase II. The 
unknown phase II disappears first upon further heating. 
 
Figure. 4 In situ ball-milling X-ray diffraction patterns for the S/DL system, 
λ = 1 Å, 1:1 ratio: (a) MeOH-, (b) EtOH-, (c) ISPN-, and (d) ACN-LAG. Colored 
bands on the right side of each image represent the presence of phases and are 
shown only for illustrative purpose. 
From the in situ variable-temperature PXRD data, it follows 
that 2:3 S/L phase must have the highest melting point among 
the S/L cocrystal phases as it is the last phase registered 
before complete melting (Figs. 2, 3, and S4.1.1). The 
1:1 S/L pol I cocrystal should have a lower melting point than 
1:1 S/L pol II as it disappears first upon heating. However, the 
exact determination of the melting points of both polymorphs 
was difficult due to the complexity of the DSC curves (Figs. 
S4.3.1-S4.3.3) 
The possibility of the formation of cocrystal hydrates was 
checked by performing LAG in the presence of water. No new 
phases were detected (see samples 17-19 in Table S4.1). 
In conclusion, for the S/L combination we identified multiple 
polymorphs and stoichiometrically diverse cocrystals (1:1, 1:2, 
and 2:3). In situ ball-milling revealed the presence of 
intermediate phases that differed depending on the solvent 
used, even though the final reaction product was the same. 
Variable-temperature in situ PXRD provided insight into the 
stability of various forms upon heating, with the 1:1 S/L pol I 
being the least thermally stable, and the 2:3 S/L having the 
highest thermal stability among the S/L forms. 
S-naproxen/D-proline (S/D) 
S/D system turned out to be the simplest: only one 1:1 S/D 
cocrystal, whose structure has already been reported28 (CCDC 
REF FEVZOX28), was detected in our experiments (see Table 
S5.1 for the summary of performed experiments). Since 
preliminary laboratory experiments did not yield any new 
forms, we decided not to explore this combination any further. 
However, we accept the possibility that other cocrystal forms 
may emerge if screening conditions are changed, e.g., if other 
cocrystallization techniques are used, but this aspect goes 
beyond the scope of the present work. 
S-naproxen/DL-proline 
S/DL system yielded several forms: one cocrystal with the 1:1 
stoichiometry, one with the 1:2 stoichiometry, and one 1:1 
cocrystal hydrate (see Scheme 1). Laboratory LAG experiments 
(see Table S9.1) showed that varying the solvent in LAG hardly 
affected the reaction outcome: MeOH-, EtOH-, ISPN-, and 
ACN-LAG reactions led to the same products: 1:1 LAG reactions 
resulted in 1:1 S/DL as the main product and both the 1:2 S/DL 
and 1:1 S/DL/H2O phases as impurities; 1:2 LAGs gave only 1:2 
S/DL without significant amounts of impurities; in 2:1 LAGs, we 
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observed mainly 1:1 S/DL and unreacted S-nprx; and finally 2:3 
LAGs resulted in mixtures of the 1:1 S/DL and 1:2 S/DL phases. 
These results were in agreement with the in situ ball-milling 
experiments (Fig. 4). All the in situ monitored reactions in the 
presence of the aforementioned four solvents led to (1:1 S/DL 
+ 1:2 S/DL) mixtures (samples 5-8 in Table S3.1). In the MeOH-
LAG the 1:2 S/DL and the 1:1 S/DL phases seem to start 
emerging approximately at the same time (Figs. 4a and 
S3.1.15). In the EtOH-LAG sample, the 1:2 S/DL clearly starts 
emerging slightly earlier than the 1:1 S/DL (Figs. 4b and 
S3.1.16). Finally, the ISPN- and ACN-LAG samples clearly show 
that the 1:2 S/DL emerges first and the 1:1 S/DL phase 
appears later (starting from the 5-6th min of reaction) (Figs. 4c 
and d). These results indicate that the 1:2 form is more 
kinetically favorable than the 1:1 form. However, both the 1:2 
S/DL and 1:1 S/DL are relatively stable and, therefore, once 
formed, do not undergo further conversion (or the rate of 
conversion is very low), which explains why the final powders 
after grinding contain both those phases in significant 
amounts. As was shown in our previous work41, solvent can 
affect the reaction rate, which is why it takes longer for the 
initial reactants to react in ACN- and ISPN-LAG than in MeOH- 
and EtOH-LAG reactions: the initial reactants stay until the 5-
6th min in ACN- and ISPN-LAG reactions, whereas they 
completely disappear already by the 2nd and 4th min in MeOH- 
and EtOH-LAG, respectively. Performing reactions in the 
presence of various solvents to vary the reaction rate helps 
establishing the order in which the reaction products emerge: 
in our particular case, slow ACN- and ISPN-LAGs showed the 
most clearly that the 1:2 S/DL phase is more kinetically 
favored than the 1:1 S/DL under grinding conditions. 
As many of the laboratory grinding experiments for this system 
yielded multiphase samples, we performed variable-
temperature in situ synchrotron X-ray diffraction 
measurements for selected powders in order to establish 
relative stabilities of the phases and their behavior upon 
heating. All the selected samples behaved in a similar manner 
(samples 1, 9, 11, and 13 in Table S9.1). Figure 5 demonstrates 
one of the examples: a sample prepared by 1:1 MeOH-LAG, 
which initially contained a mixture of 1:1 S/DL, 1:2 S/DL, and 
1:1 S/DL/H2O (other examples can be found in Figs. S9.1.1-
S9.1.3). When the sample is subjected to heating, first the 1:1 
S/DL/H2O impurity disappears followed by the disappearance 
of the 1:1 S/DL phase, which leaves pure 1:2 S/DL until it melts 
around 170°C, thereby showing that the latter is the most 
thermally stable among the S/DL phases.  
Water-assisted grinding favors the formation of the 
1:1 S/DL/H2O phase (samples 17-20 in Table S9.1). As was 
mentioned above the presence of this phase was also 
observed in other laboratory LAG experiments (see Fig. S9.1.4 
for the comparison of the 1:1 MeOH- and water-LAG reaction 
products). 
In order to understand how the hydrated S/DL form will 
behave upon heating, we performed variable-temperature in 
situ synchrotron PXRD. We did not observe any new phases. 
Upon heating, the disappearance of the 1:1 S/DL/H2O was 
followed by the emergence of a (1:1 + 1:2 S/DL) mixture, 
which upon further heating exhibited the same behavior as the 
other measured samples: the 1:1 S/DL phase melted before 
the 1:2 S/DL (Fig. 6).  
 
Figure 5. PXRD patterns measured in situ upon heating (from 31 to 175 °C, 
2 °C/min) for the S/DL sample prepared by 1:1 MeOH-LAG (sample 1 in Table 
S9.1), λ = 0.77663 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 31 °C – 1:1 S/DL, 1:2 S/DL, and 1:1 S/DL/H2O  (marked as ‘*’); 
T = 117 °C – 1:1 S/DL and 1:2 S/DL; and T = 150 °C – 1:2 S/DL. 
 
Figure 6. PXRD patterns measured in situ upon heating (from 18 to 175 °C, 
2 °C/min) for the S/DL sample prepared by 1:1 water-LAG (sample 17 in Table 
S9.1), λ = 0.798 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 18 °C – 1:1 S/DL/H2O and S-nprx  (marked as ‘*’); T = 85 °C – 
1:1 S/DL, 1:2 S/DL, and S-nprx; and T = 150 °C – 1:2 S/DL. 
We thus conclude that the S/DL system was also 
stoichiometrically diverse, showing 1:1 and 1:2 cocrystals. 
Water-LAG led to the formation of a cocrystal hydrate. In situ 
ball-milling experiments revealed that the 1:2 S/DL phase is 
more kinetically favored under those conditions and emerges 
before the 1:1 S/DL (the reaction rate depends on the solvent 
used). Finally, the in situ variable temperature experiments 
showed that the 1:2 S/DL has the highest thermal stability and 
melts the last among the S/DL phases. 
RS-naproxen/L-proline (RS/L) 
As shown in Scheme 1, we found 6 cocrystals for the RS/L 
system: three 1:1 polymorphs, one 1:2 cocrystal, one 1:1 
cocrystal hydrate, and one 1:1 cocrystal methanol solvate.  
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Figure. 7 In situ ball-milling X-ray diffraction patterns for the RS/L system, 
λ = 1 Å, 1:1 ratio: (a) MeOH-, (b) EtOH-, (c) ISPN-, and (d) ACN-LAG. Colored 
bands on the right side of each image represent the presence of phases and are 
shown only for illustrative purpose; the area outlined by purple in (d) shows the 
presence of the unknown phase IV 
The analysis of laboratory LAG experiments showed that the 
reaction outcome is solvent-dependent: 1:1 MeOH-, EtOH-, 
and ISPN-LAG resulted in the 1:1 RS/L pol I cocrystal, whereas 
ACN-LAG led to the 1:1 RS/L pol II (samples 1, 5, 9, 13 in Tables 
S6.1 and S7.1). When the initial ratio of the components in 
laboratory EtOH- and ISPN-LAG was taken so that pro was 
present in an excess amount (1:2 or 2:3 nprx : pro ratio), the 
final powders, besides the 1:1 RS/L pol I also contained the 1:2 
RS/L phase (see samples 6, 8, 10, and 12 in Tables S6.1 and 
S7.1). Varying the ratio between the components in MeOH- 
and ACN-LAG reactions, led to the 1:1 RS/L pol I or 1:1 RS/L 
pol II, respectively, and some of the initial material as impurity 
(see samples 2-4 and 14-16 in Tables S6.1 and S7.1), except 2:3 
ACN-LAG reaction (sample 16 in Table S7.1) where the 
presence of the 1:2 RS/L as a coproduct was detected as well. 
Hence, the 1:1 RS/L pol II was detected only in the ACN-LAG 
reactions; 1:2 RS/L was observed mainly in the ISPN- and 
EtOH-LAG, often as a coproduct of the 1:1 RS/L pol I. 
The results of the in situ ball-milling experiments for this 
system (Fig. 7) differed from our laboratory LAG reactions: 
grinding with all four tested solvents led to the formation of 
the 1:1 RS/L pol I phase, showing no traces of the 
1:1 RS/L pol II even in ACN-LAG, which in the laboratory 
experiments always resulted in the 1:1 RS/L pol II (samples 9-
12 in Table S3.1). Distinguishing between the two 1:1 
polymorphs was complicated due to their close diffraction 
patterns. In order to be sure that we do not have the pol II in 
the final powders we remeasured PXRD data for those samples 
at the laboratory diffractometer (Fig. S3.1.11): all the four 
samples after 1:1 MeOH-, EtOH-, ISPN- and ACN-LAG reactions 
contained only the 1:1 RS/L pol I. 
MeOH- and ISPN-LAG in situ ball-milling showed the formation 
of only the 1:1 RS/L pol I (Figs. 7a, d and S3.1.5, S3.1.7). These 
two reactions differed only by the reaction rate, which was 
slower in the case of ISPN-LAG (in the latter, the initial 
reactants disappeared only be the 6th min of reaction against 
less than by the 1st min in the case of MeOH-LAG). 
In situ EtOH-LAG showed the emergence and then 
disappearance of the 1:2 RS/L phase at the early stage of 
reaction (Figs. 7b and S3.1.6). Moreover, ACN-LAG revealed 
the emergence of another unknown phase (unknown phase 
IV) whose diffraction pattern did not correspond to any 
previously identified phases (Figs. 7c and S3.1.8). 
Unfortunately, due to poor quality of the data, reliable 
determination of this phase was impossible. 
Hence, in situ ball-milling data showed that the reaction 
pathway differs depending on the solvent used. Since the 
results were inconsistent with the preliminary laboratory 
grinding experiments, we conclude that the reaction is highly 
sensitive to the milling conditions, which renders a direct 
comparison of the laboratory grinding and in situ ball-milling 
unreliable in this case. 
Additional in situ ball-milling experiments were performed for 
the 1:2 MeOH- and ISPN-LAG reactions (samples 13 and 14 in 
Table S3.1) in order to monitor the formation of the 1:2 RS/L. 
Unfortunately, the MeOH-LAG data had a very poor quality 
and we were able only to collect the PXRD pattern of the final 
powder, which showed no presence of 1:2 RS/L, only 1:1 RS/L 
pol I and initial compounds as impurities (Fig. S3.1.10). The 
ISPN-LAG, on the other hand, clearly showed the formation of 
the 1:2 RS/L, that started emerging later (around the 4th min of 
reaction) than the 1:1 RS/L pol I (which was observed already 
after 1 min). The final powder contained both the 1:1 RS/L pol 
I and 1:2 RS/L (Figs. S3.1.9 and S3.1.18). These two results 
were consistent with our laboratory data, in which the 
formation of the 1:2 RS/L phase was observed only in ISPN-
LAG (sample 10 in Tables S6.1 and S7.1), whereas 1:2 MeOH-
LAG showed no traces of this phase, but only the 1:1 RS/L pol I 
(sample 2 in Tables S6.1 and S7.1). 
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Variable temperature in situ PXRD helped structure 
determination of the 1:2 RS/L phase providing access to its 
pure diffraction pattern (Fig. 8). The 1:2 RS/L phase was always 
obtained in a mixture with other phases and thus indexing and 
structure determination were tricky at ambient conditions. 
The variable temperature experiment showed that the 1:2 
RS/L phase is more stable upon heating and thus disappears 
later than the 1:1 RS/L pol I: the sample in the temperature 
range from 127 to 144 °C contained almost pure 1:2 RS/L (the 
amount of L-pro was negligible). 
 
Figure 8. PXRD patterns measured in situ upon heating (from 39 to 163 °C, 
2 °C/min) for the RS/L sample prepared by 1:2 ISPN-LAG (sample 10 in 
Table S7.1), λ = 0.708 Å: (left) film representation; (right) XRD patterns at 
selected temperatures: T = 39 °C – 1:1 RS/L pol I, 1:2 RS/L, and L-pro; 
T = 135 °C – 1:2 RS/L and L-pro; and T = 150 °C – L-pro. 
 
Figure 9. PXRD patterns measured in situ upon heating (from 17 to 175 °C, 
2 °C/min) for the RS/L sample prepared by 1:1 water-LAG (sample 17 in Table 
S7.1), λ = 0.78487 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 17 °C – 1:1 RS/L/H2O, RS-nprx (marked as ‘*’); T = 129 °C – 
1: 1 RS/L pol III; and T = 163 °C – 1:1 RS/L pol I. 
Water-LAG in this system yielded already known 1:1 RS/L/H2O 
cocrystal hydrate (CCDC REF BEXGUI28, samples 17-19 in Tables 
S6.1 and S7.1). Using variable-temperature in situ PXRD for this 
sample we found another polymorph – 1:1 RS/L pol III (Fig. 9), 
which was not observed in any other LAG experiments. This 
new pol III emerged upon heating when water evaporated 
from the initial hydrated sample; upon further heating pol III 
disappeared followed by the appearance of the 1:1 RS/L pol I. 
From the structural point of view, the 1:1 RS/L/H2O and 1:1 
RS/L pol III exhibit completely different types of packing (the 
former being of the Type I and the latter of Type II, (see 
Structural analysis section for the description of the packing 
types and Fig. S10.2 for the comparison of this particular case), 
thereby showing that water evaporation from the hydrated 
1:1 RS/L/H2O cocrystals induces an entire structural 
rearrangement, leading the cocrystal with a completely 
different structural type than other cocrystal forms from this 
system (which all exhibit the Type I packing). 
In conclusion, the RS/L system exhibits cocrystals with various 
stoichiometries (1:1 and 1:2), including a hydrate and a 
solvate. In situ ball-milling showed that LAG reactions are 
highly sensitive to the solvent used as well as the experimental 
setup and also revealed that even if the final product is the 
same, the reaction pathway is solvent-dependent. Variable-
temperature in situ PXRD data helped determining the 
structure of the 1:2 RS/L phase and gave access to the 1:1 RS/L 
pol III that was not observed under any other conditions. 
RS-naproxen/DL-proline 
For the RS/DL system we found two polymorphs with the 1:1 
stoichiometry – 1:1 RS/DL pol I and 1:1 RS/DL pol II, – and one 
1:1 RS/DL/H2O cocrystal hydrate (the structure of the cocrystal 
hydrate was previously reported, CCDC BEYTUW28). We also 
established the formation of the (1:2 R/DL + 1:2 S/DL) 
conglomerate under certain conditions (Scheme 1). 
In general, the laboratory LAG experiments mainly yielded the 
1:1 RS/DL pol I cocrystal (Table S8.1). The formation of the 
conglomerate was observed when the initial RS-nprx and DL-
pro were ground in 1:2 or 2:3 ratio, often as a coproduct of the 
1:1 RS/DL pol I phase (samples 2, 4, 6, 8, 10, 12, 14, 16 in Table 
S8.1); the presence of the (1:2 R/DL + 1:2 S/DL) conglomerate 
was also detected in the 1:1 ISPN-LAG (sample 9 in Table S8.1). 
The fact that we dealt exactly with the conglomerate and not 
any other combination of phases was confirmed by variable-
temperature in situ PXRD. The sample obtained by 1:2 MeOH-
LAG was heated in a capillary. Initially, the sample contained a 
mixture of different phases: 1:1 RS/DL pol I, 
(1:2 R/DL + 1:2 S/DL) conglomerate, and DL-pro monohydrate. 
Upon heating, first DL-pro monohydrate transformed into 
unhydrated DL-pro, which upon further heating disappeared 
along with 1:1 RS/DL pol I phase, leaving only the pure 
conglomerate (Fig. 10). The in situ variable temperature PXRD 
data are in agreement with the DSC, which show that the 
melting point of the 1:1 RS/DL pol I phase is lower than the 
eutectic point of the conglomerate (152(1) against 168(1)°C, 
respectively) and thus, the former should melt before the 
latter. 
Figure 10. PXRD patterns measured in situ upon heating (from 33 to 147 °C, 
2 °C/min) for the RS/DL sample prepared by 1:2 MeOH-LAG (sample 2 in 
Table S8.1), λ = 0.708 Å: (left) film representation; (right) XRD patterns at 
selected temperatures: T = 33 °C – 1:1 RS/DL pol I, (1:2 R/DL + 1:2 S/DL) 
conglomerate, and DL-pro monohydrate; T = 82 °C – 1:1 RS/DL pol I, 
(1:2 R/DL + 1:2 S/DL) conglomerate, and DL-pro; and T = 138 °C –
 (1:2 R/DL + 1:2 S/DL) conglomerate. 
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Figure 11. In situ ball-milling X-ray diffraction patterns for the RS/DL system, 
λ = 1 Å: (a) 1:1 MeOH-, (b) 1:1 ISPN-, (c) 1:2 MeOH-LAG and (d) 1:2 ISPN-LAG. 
Colored bands on the right side of each image represent the presence of phases 
and are shown only for illustrative purpose. 
In situ 1:1 ball-milling, neither in the presence of MeOH nor 
ISPN, showed conglomerate formation (samples 15 and 16 in 
Table S3.1). ISPN-LAG led directly to the 1:1 RS/DL pol I phase 
(Fig. 11b). MeOH-LAG revealed 1:1 RS/DL/H2O emerging at the 
beginning of the reaction and then disappearing shortly (Figs. 
11a and S3.1.12). 
On the other hand, when the ratio was changed for 1:2, in situ 
ball-milling in the presence of both MeOH and ISPN showed 
the formation of the conglomerate (samples 17 and 18 in 
Table S3.1). In 1:2 MeOH-LAG, the final powder contained both 
the conglomerate and the 1:1 RS/DL pol I: the conglomerate 
started to emerge first and the 1:1 phase followed (Fig. 11c 
and S3.1.13); moreover, we detected again the formation of 
the 1:1 RS/DL/H2O within the 1st min of reaction, which later 
disappeared. In 1:2 ISPN-LAG, the final sample contained only 
the conglomerate, whose emergence was preceded by the 1:1 
RS/DL pol I phase, which disappeared already after 8 min of 
grinding (Fig. 11d and S3.1.14). These experiments show that 
the conglomerate and the 1:1 RS/DL pol I phase kinetically 
compete with each other and the result significantly depends 
on the reaction conditions. 
Water-assisted laboratory grinding yielded the 1:1 RS/DL/H2O 
cocrystal hydrate (samples 17-19 Table S8.1), which upon 
heating transformed into the 1:1 RS/DL pol II phase when 
water evaporated from the sample. Upon further heating the 
1:1 RS/DL pol II simply melted without any other phases 
emerging (Fig. 12). The 1:1 RS/DL pol II cocrystal was not 
detected upon any other tested conditions. Comparing 
1:1 RS/DL/H2O and 1:1 RS/DL pol II showed that the hydrated 
structure undergoes a complete structural rearrangement 
upon heating, with the final unhydrated structure being of the 
Type II packing, unlike the initial hydrated form and the 1:1 
RS/DL pol I cocrystal both belonging to the Type I packing (see 
Structural analysis section for the description of the packing 
types and Fig. S10.3 for the comparison of this particular case). 
 
Figure 12. PXRD patterns measured in situ upon heating (from 17 to 170 °C, 
2 °C/min) for the RS/DL sample prepared by 1:1 water-LAG (sample 17 in Table 
S8.1), λ = 0.78487 Å: (left) film representation; (right) XRD patterns at selected 
temperatures: T = 17 °C – 1:1 RS/DL/H2O, RS-nprx (marked as ‘*’), and DL-pro 
monohydrate (marked as ‘†’); T = 114 °C – 1:1 RS/DL pol II and RS-nprx; and T = 
155 °C – 1:1 RS/DL pol II. 
Hence, the most interesting finding for the RS/DL system is the 
formation of the (1:2 R/DL + 1:2 S/DL) conglomerate under 
certain conditions. In situ variable-temperature PXRD data 
were essential to prove this fact as they provided access to the 
diffraction pattern of the pure conglomerate.  Another in situ 
variable-temperature PXRD experiment allowed structure 
solution of the 1:1 RS/DL pol II, as this phase was observed 
only upon heating and not under any other tested conditions. 
Structural analysis 
In our previously published work41, we studied the 
flurbiprofen/proline system, which similarly to 
naproxen/proline showed a great variety of cocrystal phases. 
Below, we will analyse the structural features of nprx/pro 
cocrystals and compare them to those seen in the 
flurbiprofen/proline system. 
Unlike flurbiprofen/proline cocrystals, for which we 
distinguished 4 packing types41, nprx/pro cocrystals exhibit 
less variability–only two types of packing were found (Scheme 
2): 1) Type I – sandwich-like type, in which pro chains form a 
center layer with nprx attached from both sides; 2) Type II –
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 layer type, in which one can distinguish alternating layers of 
pro and nprx, with nprx arranged in a zip-like manner. 
Moreover, Type I can be divided into two subtypes, a and b, 
which differ from one another by the arrangement of nprx 
molecules: in the Ia subtype, nprx packs in a herringbone 
manner and in the IIb type nprx molecules are parallel. 
Schematic representation of these packing types and 
illustrating examples are given in Fig. 13.   
Scheme 2. Structural types distinguished for the nprx/pro cocrystals    
Pro is zwitterionic in all the structures and form head-to-tail 
chains through charge-assisted N–H…O hydrogen bonds, which 
are typical of crystalline pro and other amino acids.25–27 Nprx 
attaches to pro via O–H…O hydrogen bonds between the 
carboxyl group and carboxylate, respectively. 
Figure 13. Schematic representation of the structural types distinguished for the 
nprx/pro system. Blue pentagons and green pointed (the COOH group 
orientation) rectangles represent pro and nprx molecules, respectively. Type I is 
the sandwich-like type, separate sandwiches are colored pink and yellow in the 
structure examples; Type II is the layer type: alternating nprx and pro layers are 
colored green and blue, respectively, in the structure example. 
The fact that nprx/pro cocrystals vary less in their structural 
features than flurbiprofen/proline cocrystals may be related to 
the structural peculiarities of nprx and flurbiprofen 
themselves. Pure flurbiprofen exhibits polymorphism (CCDC 
FLUBIP58 (P-1) and FLUBIP0259 (P21/n)) and we found that the 
packing in cocrystal structures resembled that of pure 
flurbiprofen, whereas in the case of nprx, no polymorphism 
has been reported so far. Both racemic and enantiopure nprx 
structures exhibit a similar general packing motif: nprx dimers 
are arranged in a stacking manner to enable efficient π-π 
overlap between the benzene rings. S-nprx/ethanol solvate, 
which we obtained from ethanol solution, also exhibited the 
same packing motif as non-solvated nprx, with ethanol 
molecules “wedged” in between nprx dimers (see Fig. S10.1). 
Since ethanol was essential to keep the structure together, the 
latter turned out to be very unstable if exposed to air. Thus, 
pure nprx is less prone to polymorphism and thus results in a 
fewer variants of packing in cocrystals, in comparison with 
flurbiprofen. 
Previously reported cocrystals of nprx and amino acids17 also 
demonstrated the same types of packing: nprx/alanine (CCDC 
RODSEK and RODSIO17) and nprx/tryptophan (CCDC 
RODSOU17) had the sandwich-like type (I) and nprx/tyrosine 
(CCDC RODSUA17) exhibited the layer type (II) packing. Hence, 
we suspect that, since nprx prefers a stacking manner of 
molecular arrangement, the weak interactions between its 
bulky molecules are responsible for the overall packing of 
nprx/amino acid cocrystals. 
At the same time, we believe that amino acid chains, with 
strong charge-assisted hydrogen bonds between molecules, 
should provide the structure with additional stability and a 
higher melting point in comparison with the structure of the 
initial API as the percentage of strong interactions in the 
structure increases. For instance, the melting point of 
flurbiprofen/proline cocrystals was minimum 30 °C higher in 
comparison with pure flurbiprofen (Tm (racemic flurbiprofen) 
= 115 °C, Tm (enantiopure flurbiprofen) = 109 °C)41. The 
melting points of some of the nprx/pro cocrystals were also 
found to be higher than that of pure nprx (see Table 1). The 
highest melting points were observed for the cocrystals with 
the 1:2 and 2:3 stoichiometries, which can be explained by the 
fact that these cocrystals exhibit a higher percentage of 
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charge-assisted hydrogen bonds as compared with the 1:1 
phases due to an extra pro molecule in the asymmetric unit. 
The 1:1 phases on the other hand were found to have melting 
points very close to pure nprx, which highlights the fact that 
the interactions between nprx molecules themselves are 
substantial and provide efficient bonding even without strong-
charge assisted hydrogen bonds. 
Table 1. Determined melting points of the initial API and its cocrystals with pro 
Compound Melting point, °C 
S-nprx 155(1) 
RS-nprx 153(1) 
2:3 S/L 181(1) 
1:1 S/D 155(1) 
1:1 RS/L pol I 162(1) 
1:1 RS/L pol II 159(1) 
1:2 RS/L 171(1) 
1:1 RS/DL pol I 152(1) 
1:2 S/DL 182(1) 
(1:2 S/DL + 1:2 R/DL) 168(1) – eutectic point 
Another peculiar finding about nprx/pro cocrystals is the 
cocrystals of the 1:2 and 2:3 stoichiometries, in which nprx is 
connected only to one or two pro, respectively, and the rest 
pro molecules in the asymmetric unit are connected to 
themselves. In Scheme 3 we present four possibilities of the 
interactions between nprx and pro in an asymmetric unit. All 
the five combinations of racemic and/or enantiopure nprx and 
pro yielded at least one 1:1 stoichiometry cocrystal, case (a) in 
Scheme 3. Cocrystals of this type were seen in abundance in 
both the nprx/pro and flurbiprofen/pro systems. A cocrystal 
of the 1:2 stoichiometry, case (b) in Scheme 3, was also 
observed in the flurbiprofen/pro system (CCDC VEVLAM41) and 
it turns out that its structure is very similar to the 1:2 nprx/pro 
cocrystals: two perpendicularly going infinite pro chains form a 
pro layer, in which nprx is connected only to one of those 
chains (see Fig. S10.4). In the 2:3 S/L cocrystal, case (c) in 
Scheme 3, the pro layer is comprised of clusters situated one 
on top of another and made of three interconnected pro 
chains; nprx is attached to only two chains from the cluster 
(see Fig. S10.5). The last type of interactions, case (d), in which 
one pro molecule attaches two APIs via two O-H…O hydrogen 
bonds formed by its carboxylate group with two carboxyl 
groups of an API resulting in the cocrystals with the 2:1 
(API:pro) stoichiometry, was not observed in the nprx/pro 
system, even though it was very common among the 
flurbiprofen/pro cocrystals. 
Cocrystals with the aforementioned 1:2 and 2:3 
stoichiometries are less common. Their existence shows that 
in order to obtain a cocrystal of desired stoichiometry it is not 
enough to simply choose the compounds with potential 
binding sites, but it is also important to consider the possibility 
of other potentially stronger interactions that might occur 
between the molecules of one kind, like in this case, when 
instead of binding a second nprx to the available oxygen of the 
carboxylate, pro preferred to bind another symmetrically 
nonequivalent pro molecule and form a 1:2 or 2:3 (nprx : pro) 
cocrystal. 
Scheme 3. Four possibilities of interactions between profen (API) and proline 
molecules in an asymmetric unit of their cocrystals. (a), (b), and (c) cases are 
observed in the nprx/pro system; (d) case, typical of the flurbiprofen/pro 
system, was not detected for nprx/pro. Red circles represent oxygen atoms, blue 
circles represent nitrogen, green rectangles with attached -COOH group 
represent a profen molecule (API). 
Conclusions 
Nprx/pro system exhibits a wide variety of cocrystal forms: 17 
in total, whose structures were determined, plus four 
unknown phases whose structures were impossible to find. 
Similarly to the previously reported case of 
flurbiprofen/proline cocrystals41, we believe that the 
complexity of the system can be associated with the following 
two factors: first, how well the three-dimensional structures of 
the initial compounds “suit” one another to form an efficient 
packing pattern; and second, the conformational flexibility of 
the initial molecules.  
As for the first factor, the system might have a higher 
possibility of efficient packing in the case of racemic initial 
compounds in comparison with the enantiopure ones because 
having both enantiomers in the structure may increase the 
chances of “suitability”. At the same time, some of the chiral 
combinations may form stronger connections than the others. 
For instance, the S/D system showed only one cocrystal, 
whereas the S/L system yielded minimum four cocrystal 
phases. Probably, in the case of the S/D combination, the 
interactions between coformers are so efficient that they do 
not leave any chance for other polymorphs or 
stoichiometrically diverse cocrystals to emerge under studied 
conditions as the former is both thermodynamically and 
kinetically favored; whereas in the S/L system, the initial 
coformers might fit one another to a lesser degree and, thus, 
many competitive phases (probably of approximately the same 
energies) may emerge. This conclusion is speculative on our 
part, and we suggest that a careful calculation of the relative 
energies of the obtained cocrystals can shine more light on this 
chirality-related aspect of cocrystallization. 
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As for the second factor, pro has been known for its 
conformational flexibility60, moreover we found two 
polymorphs of L-pro itself in the Cambridge Structural 
Database61 (CCDC PROLIN50 and PROLIN0441). Hence, we 
believe that the conformational flexibility of pro can partly be 
responsible for the found polymorphic and stoichiometric 
diversity of the nprx/pro cocrystals. 
The melting points that we were able to determine for several 
nprx/pro cocrystals turned out to be higher than that of pure 
nprx, which is due to the pro’s ability to form charge-assisted 
hydrogen bonded chains owing to which the percentage of 
strong interaction in the structure increases in comparison 
with the pure API. As all amino acids in the crystalline state are 
zwitterionic and tend to form such chains25–27, which are also 
frequently observed in their cocrystals17,28,62, this structural 
feature of amino acid cocrystals can be especially useful when 
handling unstable APIs: one of the reported examples is the 
improvement of the stability of highly hygroscopic lactic acid, 
via its cocrystallization with tryptophan.29 
In situ ball-milling monitored by synchrotron X-ray diffraction 
has already proved vital for studying solid-state reactions.63–67 
In the current study, we used this method to verify the 
possibility of intermediate phases in our LAG reactions. We 
detected several intermediate phases emerging in the course 
of reaction. We found that the reaction pathway can be 
solvent dependent, as for instance, in the case of the S/L 
system, when in the beginning of the reaction we observed 
different phases depending on the solvent used, even though 
the final product was the same. Knowing at which moment to 
stop the reaction in order to obtain a desired product (for 
instance, one of the intermediates) can provide a better 
control of the reaction outcome. 
Synchrotron X-ray diffraction data turned out to be 
indispensable when dealing with complicated product 
mixtures. Similarly to our work on flurbiprofen/proline 
cocrystals, synchrotron X-ray diffraction data collected in situ 
upon heating allowed direct monitoring of phase changes, and 
gave access to the pure PXRD patterns of certain phases.  They 
allowed structure solution of the  1:2 RS/L cocrystal, otherwise 
observed only in mixture, helped us to confirm the 
conglomerate formation in the RS/DL system, and revealed 
the 1:1 RS/DL pol II and 1:1 RS/L pol II phases that emerged 
when the hydrated forms of the corresponding cocrystals were 
heated and water evaporated. 
The results of this work should be of great interest to 
pharmaceutical industry as they deal with various chirality 
aspects of cocrystallization of APIs, provide insight into various 
structural features of cocrystals with zwitterionic coformers via 
the example of pro, and demonstrate how clever combining 
various state-of-the-art characterization methods helps not 
only identify existing phases but also provides means for a 
better control of solid-state reactions. 
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